175 related articles for article (PubMed ID: 37181780)
1. Induced-volatolomics for the design of tumour activated therapy.
Châtre R; Blochouse E; Eid R; Djago F; Lange J; Tarighi M; Renoux B; Sobilo J; Le Pape A; Clarhaut J; Geffroy C; Opalinski I; Tuo W; Papot S; Poinot P
Chem Sci; 2023 May; 14(18):4697-4703. PubMed ID: 37181780
[TBL] [Abstract][Full Text] [Related]
2. Volatile Organic Compound Based Probe for Induced Volatolomics of Cancers.
Lange J; Eddhif B; Tarighi M; Garandeau T; Péraudeau E; Clarhaut J; Renoux B; Papot S; Poinot P
Angew Chem Int Ed Engl; 2019 Dec; 58(49):17563-17566. PubMed ID: 31518472
[TBL] [Abstract][Full Text] [Related]
3. Targeting the tumour microenvironment with an enzyme-responsive drug delivery system for the efficient therapy of breast and pancreatic cancers.
Renoux B; Raes F; Legigan T; Péraudeau E; Eddhif B; Poinot P; Tranoy-Opalinski I; Alsarraf J; Koniev O; Kolodych S; Lerondel S; Le Pape A; Clarhaut J; Papot S
Chem Sci; 2017 May; 8(5):3427-3433. PubMed ID: 28507714
[TBL] [Abstract][Full Text] [Related]
4. Induced volatolomics of pathologies.
Djago F; Lange J; Poinot P
Nat Rev Chem; 2021 Mar; 5(3):183-196. PubMed ID: 37117532
[TBL] [Abstract][Full Text] [Related]
5. VOC-Based Probes, a New Set of Analytical Tools to Monitor Patient Health from Blood Sample. Proof of Concept on Tracking COVID-19 Infection.
Blochouse E; Eid R; Araji N; Tuo W; Châtre R; Papot S; Lévêque N; Thuillier R; Poinot P
Anal Chem; 2023 Aug; 95(31):11572-11577. PubMed ID: 37405898
[TBL] [Abstract][Full Text] [Related]
6. Hybrid volatolomics and disease detection.
Broza YY; Mochalski P; Ruzsanyi V; Amann A; Haick H
Angew Chem Int Ed Engl; 2015 Sep; 54(38):11036-48. PubMed ID: 26235374
[TBL] [Abstract][Full Text] [Related]
7. A GABA Receptor Modulator and Semiochemical Compounds Evidenced Using Volatolomics as Candidate Markers of Chronic Exposure to Fipronil in
Fernandes V; Hidalgo K; Diogon M; Mercier F; Angénieux M; Ratel J; Delbac F; Engel E; Bouchard P
Metabolites; 2023 Jan; 13(2):. PubMed ID: 36837804
[TBL] [Abstract][Full Text] [Related]
8. Identification by volatolomics of hydrocarbon, oxygenated, sulfur and aromatic markers of livestock exposure to α-hexabromocyclododecane.
Ratel J; Mercier F; Angénieux M; Kondjoyan N; Abouelkaram S; Blinet P; Travel A; Royer E; Baéza-Campone E; Cariou R; Jondreville C; Engel E
Food Chem; 2022 Apr; 374():131504. PubMed ID: 34852955
[TBL] [Abstract][Full Text] [Related]
9. Nanoscale Sensor Technologies for Disease Detection via Volatolomics.
Vishinkin R; Haick H
Small; 2015 Dec; 11(46):6142-64. PubMed ID: 26448487
[TBL] [Abstract][Full Text] [Related]
10. Volatolomics in Bacterial Ecotoxicology, A Novel Method for Detecting Signatures of Pesticide Exposure?
Hidalgo K; Ratel J; Mercier F; Gauriat B; Bouchard P; Engel E
Front Microbiol; 2018; 9():3113. PubMed ID: 30671028
[TBL] [Abstract][Full Text] [Related]
11. Planning Implications Related to Sterilization-Sensitive Science Investigations Associated with Mars Sample Return (MSR).
Velbel MA; Cockell CS; Glavin DP; Marty B; Regberg AB; Smith AL; Tosca NJ; Wadhwa M; Kminek G; Meyer MA; Beaty DW; Carrier BL; Haltigin T; Hays LE; Agee CB; Busemann H; Cavalazzi B; Debaille V; Grady MM; Hauber E; Hutzler A; McCubbin FM; Pratt LM; Smith CL; Summons RE; Swindle TD; Tait KT; Udry A; Usui T; Westall F; Zorzano MP
Astrobiology; 2022 Jun; 22(S1):S112-S164. PubMed ID: 34904892
[TBL] [Abstract][Full Text] [Related]
12. A β-glucuronidase-responsive albumin-binding prodrug programmed for the double release of monomethyl auristatin E.
Renoux B; Fangous L; Hötten C; Péraudeau E; Eddhif B; Poinot P; Clarhaut J; Papot S
Medchemcomm; 2018 Dec; 9(12):2068-2071. PubMed ID: 30746064
[TBL] [Abstract][Full Text] [Related]
13. Volatolomics in healthcare and its advanced detection technology.
Hu W; Wu W; Jian Y; Haick H; Zhang G; Qian Y; Yuan M; Yao M
Nano Res; 2022; 15(9):8185-8213. PubMed ID: 35789633
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy.
Cho H; Shim MK; Moon Y; Song S; Kim J; Choi J; Kim J; Lee Y; Park JY; Kim Y; Ahn CH; Kim MR; Yoon HY; Kim K
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297566
[TBL] [Abstract][Full Text] [Related]
15. Development of an organ-on-chip model for the detection of volatile organic compounds as potential biomarkers of tumour progression.
Bayona C; Wrona M; Randelovic T; Nerín C; Salafranca J; Ochoa Garrido I
Biofabrication; 2024 Jun; ():. PubMed ID: 38866002
[TBL] [Abstract][Full Text] [Related]
16. Profiling Single Cancer Cells with Volatolomics Approach.
Serasanambati M; Broza YY; Marmur A; Haick H
iScience; 2019 Jan; 11():178-188. PubMed ID: 30612036
[TBL] [Abstract][Full Text] [Related]
17. SN38-based albumin-binding prodrug for efficient targeted cancer chemotherapy.
Huang Y; Wang L; Cheng Z; Yang B; Yu J; Chen Y; Lu W
J Control Release; 2021 Nov; 339():297-306. PubMed ID: 34619226
[TBL] [Abstract][Full Text] [Related]
18. Highly potent monomethyl auristatin E prodrug activated by caspase-3 for the chemoradiotherapy of triple-negative breast cancer.
Chung SW; Cho YS; Choi JU; Kim HR; Won TH; Kim SY; Byun Y
Biomaterials; 2019 Feb; 192():109-117. PubMed ID: 30447398
[TBL] [Abstract][Full Text] [Related]
19. Physiological variability in volatile organic compounds (VOCs) in exhaled breath and released from faeces due to nutrition and somatic growth in a standardized caprine animal model.
Fischer S; Trefz P; Bergmann A; Steffens M; Ziller M; Miekisch W; Schubert JS; Köhler H; Reinhold P
J Breath Res; 2015 May; 9(2):027108. PubMed ID: 25971714
[TBL] [Abstract][Full Text] [Related]
20. Volatolomics: A broad area of experimentation.
Giannoukos S; Agapiou A; Brkić B; Taylor S
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():136-147. PubMed ID: 30584978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
